Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ

NCT05970939 | Completed

• 1 other identifier: ND-Development-TrUQ
• Study Type: observational
• Target: 95
• Locations: 1 country
• Sites: 1

Brief Summary

Neurological diseases are central nervous system diseases that cause an increase in the level of disability and limitations in daily life. Multiple Sclerosis (MS), stroke, and Parkinson's Disease (PD) are among the most common apparent neurological diseases, and epidemiological studies show that their prevalence has increased over time worldwide. Although MS, stroke, and PD have different causes and neurological aspects, they generally cause motor, sensory, and/or cognitive impairments, leading to restriction of the individual's activities and participation. Today, physiotherapy and rehabilitation approaches together with optimal medical and surgical treatment are the cornerstones of treatment for these diseases. Recently, it has been stated that various telerehabilitation interventions in the field of physiotherapy and rehabilitation may be an additional option to the rehabilitation approaches applied in the clinic. On the other hand, It is important to evaluate the level of usability in expanding the usability of telerehabilitation services and determining the best telerehabilitation service. For this reason, there is a need for questionnaires investigating the satisfaction level of physiotherapy and rehabilitation applied through telerehabilitation.

Conditions

Neurological Disease

Keywords

Multiple Sclerosis; Parkinson Disease; Stroke; Usability; Telerehabilitation

Outcome Measures

Primary Outcomes (2)

• Telerehabilitation Usability Questionnaire in patients with Neurological disease

  Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale

  Baseline

• Telerehabilitation Usability Questionnaire in patients with Neurological disease-Second

  Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale

  he second assessment will be conducted after the one week

Study Arms (1)

Telerehabilitation Usability

Telerehabilitation Usability Group

Other: Development of the Telerehabilitation Usability Questionnaire

Interventions

Development of the Telerehabilitation Usability Questionnaire OTHER

This study will be examined the development, validity, and reliability of the Telerehabilitation Usability Questionnaire in patients with MS.

Telerehabilitation Usability

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Neurological patients receiving physiotherapy and rehabilitation via telerehabilitation

You may qualify if:

• Voluntarily participate in research to accept
• Mini-Mental Test score more than or equal 24
• Previously receiving physical therapy through telerehabilitation

You may not qualify if:

• Any visual, hearing, and perception problems that may affect the answering the questionnaire items

Sponsors & Collaborators

• Gazi University: lead

Study Sites (1)

Gazi University

Ankara, Turkey (Türkiye)

Location

Related Publications (1)

• Parmanto B, Lewis AN Jr, Graham KM, Bertolet MH. Development of the Telehealth Usability Questionnaire (TUQ). Int J Telerehabil. 2016 Jul 1;8(1):3-10. doi: 10.5195/ijt.2016.6196. eCollection 2016 Spring.

  PMID: 27563386 BACKGROUND

Related Links

• Reference 1

MeSH Terms

Conditions

Nervous System Diseases; Multiple Sclerosis; Parkinson Disease; Stroke

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNS; Autoimmune Diseases of the Nervous System; Demyelinating Diseases; Autoimmune Diseases; Immune System Diseases; Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases; Cerebrovascular Disorders; Vascular Diseases; Cardiovascular Diseases

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: principal investigator

Study Record Dates

• First Submitted: July 24, 2023
• First Posted: August 2, 2023
• Study Start: July 28, 2023
• Primary Completion: October 28, 2024
• Study Completion: October 28, 2024
• Last Updated: November 14, 2024

Record last verified: 2024-11

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)